Evaluating the Use of AI in Implantable Loop Recorders for AF Detection

2021 ◽  
Vol 7 (8) ◽  
pp. 1068-1069
Author(s):  
Afsan Ahmed ◽  
Mahmood Ahmad
2014 ◽  
Vol 17 (3) ◽  
pp. A116
Author(s):  
J Rogers ◽  
S. Chang ◽  
M.E. Quiroz ◽  
T. Madden ◽  
A. Diamantopoulos ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Karapet Davtyan ◽  
Victoria Shatakhtsyan ◽  
Hermine Poghosyan ◽  
Alexandr Deev ◽  
Alexey Tarasov ◽  
...  

Introduction. While several studies have compared the radiofrequency current (RFC) and cryoablation for the treatment of patients with atrial fibrillation (AF), no study has monitored the long-term outcomes with the usage of implantable loop recorders (ILRs). Methods. We enrolled 89 consecutive patients with nonvalvular paroxysmal AF (N=44 for RFC and N=45 for cryoballoon). The primary efficacy end point was the assessment of effectiveness for each group (RFC versus cryoballoon) when examining freedom from arrhythmia by monitoring with ECG, Holter, and implantable loop recoder (ILR). The primary safety end point compared rates of adverse events between both groups. The secondary efficacy end point examined the duration of the postablation blanking period from ILR retrieved data. Results. The mean age of the study population was 56.6±10.2 years, and the follow-up duration was 12 months. There were no differences in baseline patient characteristics between groups. At 12 months, the absolute effectiveness (measured by ILR) was 65.9% in the RFC group and 51.1% in the cryoballoon group (OR = 1.85; 95% CI: 0.79–4.35; p=0.157), and the clinical effectiveness (measured by ECG and Holter) was 81.8% in the RFC group and 55.6% in the cryoballoon group (OR = 3.6; 95% CI: 1.37–9.46; p=0.008). There was no difference in safety between both groups. Asymptomatic episodes were significantly more present in the RFC group as measured by ILRs (p<0.010). In cryoballoon group, arrhythmia episodes were recorded equally irrespective of the follow-up method (i.e., ECG and Holter versus ILR (p>0.010)). The blanking period does not seem to be as important in cryoballoon as compared to RFC. Conclusion. RFC and cryoballoon ablation had similar absolute effectiveness at 12 months. ECG and Holter were effective when assessing the efficacy of the cryoballoon ablation; however, in the RFC group, ILR was necessary to accurately assess long-term efficacy.


Author(s):  
Maximilian Kremer ◽  
Herbert Nägele ◽  
Eike Gröne ◽  
Daniel Stierle ◽  
Michael Rosenkranz ◽  
...  

Author(s):  
Catherine J. O’Shea ◽  
Melissa Middeldorp ◽  
Jeroen M. Hendriks ◽  
Anthony G. Brooks ◽  
Curtis Harper ◽  
...  

EP Europace ◽  
2009 ◽  
Vol 11 (3) ◽  
pp. 303-307 ◽  
Author(s):  
D. Kenny ◽  
S. Chakrabarti ◽  
A. Ranasinghe ◽  
A. Chambers ◽  
R. Martin ◽  
...  

2013 ◽  
pp. 239-253
Author(s):  
Rajesh N. Subbiah ◽  
Pow-Li Chia ◽  
Peter Leong-Sit ◽  
Lorne J. Gula ◽  
Allan C. Skanes ◽  
...  

EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii234-iii234
Author(s):  
B. Yeneneh ◽  
J. Munro ◽  
S. Wilansky ◽  
J. Behai ◽  
L. Scott

2017 ◽  
Vol 117 (10) ◽  
pp. 1962-1969 ◽  
Author(s):  
Carsten Israel ◽  
Alkisti Kitsiou ◽  
Malik Kalyani ◽  
Sameera Deelawar ◽  
Lucy Ekosso Ejangue ◽  
...  

SummaryRecently, the clinical entity embolic stroke of undetermined source (ESUS) has been defined for patients with ischemic strokes, where neither a cardioembolic nor a non-cardiac source can be detected. These patients may suffer from asymptomatic atrial fibrillation (AF), terminating spontaneously and thus eluding detection. Implantable loop recorders (ILR) with automatic AF detection algorithms can detect short-lasting, subclinical AF. The aim of this study was to prospectively assess and predict AF detection in patients with ESUS using ILR with daily remote interrogation. Patients with acute ESUS received an ILR, were seen every 6 months and additionally interrogated their ILR daily using remote monitoring. The incidence of AF detection was assessed and parameters which might predict AF detection (clinical and from magnetic resonance tomography) were analysed. ILR implantation was performed in 123 patients on average 20 days after stroke. During a mean follow-up of 12.7±5.5 months, AF was documented and manually confirmed in 29 of 123 patients (23.6%). First AF detection occurred on average after 3.6±3.4 months of monitoring. Patients with AF were on average older, had a higher CHA2DS2-VASc score and more often cerebral microangiopathy. In conclusion, AF can be documented in approximately 25% of patients with the diagnosis of ESUS after careful work-up within a year of monitoring by an ILR and daily remote interrogation. This had important therapeutic consequences (initiation of anticoagulation for secondary stroke prevention) in these patients.


Sign in / Sign up

Export Citation Format

Share Document